Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19

Detalles Bibliográficos
Autores principales: Bakshi, Satvinder Singh, Bakshi, Sumita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575547/
https://www.ncbi.nlm.nih.gov/pubmed/34776728
http://dx.doi.org/10.1186/s43162-021-00070-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575547/
https://www.ncbi.nlm.nih.gov/pubmed/34776728
http://dx.doi.org/10.1186/s43162-021-00070-z

Ejemplares similares